IL96148A0
(en )
1991-07-18
Tissue moisturizing composition
HUP0003173A3
(en )
2001-03-28
Use of glp-1 or analogs for preparing pharmaceutical compositions useful in treatment of myocardial infarction
GB8506430D0
(en )
1985-04-17
Resection endoscope
HUT42332A
(en )
1987-07-28
Electrodcatheter for ablation of his-fascicule
IL135951A0
(en )
2001-05-20
Antimutagenic compositions for the treatment and prevention of photodamage to skin
ZA93323B
(en )
1994-07-18
Preparation of fluorinated functional compounds.
EP0235544A3
(en )
1989-11-29
Ocular antihypertensive composition for topical use
GB9505242D0
(en )
1995-05-10
Improvements to the patterning of tissue paper
DE3567374D1
(en )
1989-02-16
Composition for ophthalmological use
HUT75339A
(en )
1997-05-28
Preparation of purines
ZA931489B
(en )
1993-10-28
Use of interleuken-10 to suppress graft-vs-host disease
NZ240658A
(en )
1993-04-28
Use of furfural as nematicide
AU4596896A
(en )
1996-06-26
Substituted benzamides and radioligand analogs and methods of use
IL100074A0
(en )
1992-08-18
Preparation of diethers
EP0413929A3
(en )
1992-01-08
Use of an ace-inhibitor to treat or prevent depression
GB8810422D0
(en )
1988-06-08
Ophthalmological composition of matter
GB2195650B
(en )
1990-07-11
Composition for skin cleansing
EP0543902A4
(en )
1993-10-27
Use of metalloporphyrins to potentiate aids therapy
ZA977753B
(en )
1998-09-10
Use of glp-1 or analogs to abolish catabolic changes after surgery
EP0288685A3
(en )
1990-10-31
Use of pyrrolidone derivatives as anti-amnestic agents
ZA872736B
(en )
1987-10-08
Use of 3-carbamoyl-4-hydroxy-coumarins for combating parasitic helminths,new 3-carbamoyl-4-hydroxy-coumarins and their preparation
EP0738154A4
(en )
1996-04-12
N-terminus modified analogs of lhrh
ZA945717B
(en )
1995-05-19
Preparation of electrode
HUP0000483A3
(en )
2001-02-28
Use of aminoisothiazoles as microbicides
HUP0000271A3
(en )
2000-10-30
Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery